Senior InfoSec Risk & Reporting Leader

Novo Nordisk; Ballerup Kommune; On-site; DKK 847,000 - 1,245,000; Full time

Job summary

Novo Nordisk is seeking a Senior Information Security Advisor to strengthen how information security risks are identified, understood and reported across Novo. You will turn complex risk information into clear insight that leaders and risk owners can act on, helping the business make well-informed decisions at pace.

Your work will help protect Novo's ability to keep serving people living with serious chronic diseases worldwide.

Qualifications

• 10+ years of experience within Information Security or a related discipline.
• Hands-on experience facilitating and conducting risk assessments in a complex environment.
• Experience developing risk reporting and presenting findings to senior stakeholders.
• Strong knowledge of information security principles and industry frameworks (ISO 27001/27002, NIST CSF, SOC 2).
• Excellent stakeholder management, communication and facilitation skills.

Responsibilities

• Facilitate IT/OT and information security risk processes across Novo and report risks to leaders.
• Drive and improve the risk management framework, methodologies and processes.
• Prepare high-quality reporting materials for leadership, governance forums and senior management.
• Communicate complex risk information in a clear, business-relevant way.
• Promote a strong, proactive risk culture across the organisation.
• Support integration of information security risks into enterprise risk management and governance.

Skills

10+ years information security

Risk assessments

Risk reporting

Information security standards

Stakeholder management

Job description

Novo Nordisk is seeking a Senior Information Security Advisor to strengthen how information security risks are identified, understood and reported across Novo. You will turn complex risk information into clear insight that leaders and risk owners can act on, helping the business make well-informed decisions at pace.

Your work will help protect Novo's ability to keep serving people living with serious chronic diseases worldwide.